Rajesh K. Kesharwani

Rajesh K. Kesharwani, M.Tech, PhD, has more than 8 years of teaching & research experience in various institutes of India, imparting bioinformatics and biotechnology education. He has received several awards, including the NASI-Swarna Jayanti Puruskar-2013 by The National Academy of Sciences of India. He has authored over 34 peer-reviewed articles, sixteen book chapters and six books as co-editor with publishers of repute. He has been a member of many scientific communities as well as a reviewer for many international journals. His research fields of interest are medical informatics, protein structure and function prediction, computer aided drug designing, structural biology, drug delivery, cancer biology and next generation sequence analysis. Dr. Kesharwani received a BSc in biology from Ewing Christian College, Allahabad, India, an autonomous college of University of Allahabad; his MSc (Biochemistry)from Awadesh Pratap Singh University, Rewa, Madhya Pradesh, India; and MTech-IT (Specialization in Bioinformatics) from the Indian Institute of Information Technology, Allahabad, India. He earned his Doctorate (Ph.D.) from the Indian Institute of Information Technology, Allahabad and received a Ministry of Human Resource Development, India, fellowship and Senior Research Fellowship from the Indian Council of Medical Research, India.

Publications

Nutraceutical and Functional Foods in Disease Prevention
Raj K. Keservani, Anil K. Sharma, Rajesh K. Kesharwani. © 2019. 569 pages.
Current research on health, nutrition, and preventative care will always be in demand. As the battles against ailments such as diabetes and heart disease continue, medical...
Preface
Raj K. Keservani, Anil K. Sharma, Rajesh K. Kesharwani. © 2017. 4 pages.
This Preface is included in the book Novel Approaches for Drug Delivery.
Preface
Raj K. Keservani, Anil K. Sharma, Rajesh K. Kesharwani. © 2017. 4 pages.
This Preface is included in the book Recent Advances in Drug Delivery Technology.
Biosimilars: Concept and Regulation
Anil K. Sharma, Raj K. Keservani, Rajesh K. Kesharwani. © 2017. 18 pages.
Biosimilars are a new class of drugs, which are derived from live organism through the recombinant DNA technology. These are recently introduced in the pharmaceutical field for...